| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","company":"RECURSION PHARMACEUTICALS, INC.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","article_chars":1675,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_068a1fc49125069c","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","content_type":"text/plain","enriched_at":"2026-04-09T19:13:38.065567+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","source_event_id":"evt_c652e4f7b407","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"9387f60aca55d981","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-08","2026-04-07","2025-08-31","2014-03-05"],"entities":[{"asset_class":"equity","name":"Recursion Pharmaceuticals, Inc.","relevance":"high","symbol":"RXRX","type":"issuer"},{"asset_class":"person","name":"Blake Borgeson","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"other","name":"Rule 10b5-1 trading plan","relevance":"medium","symbol":"","type":"legal_framework"}],"event_type":"listing","information_gaps":["The extracted text does not clearly show the transaction type (e.g., buy/sell), number of shares, price per share, or total value; only partial numeric fragments appear (e.g., \u201c30000\u201d, \u201c3.10\u201d, \u201c6229863\u201d) without sufficient context to confirm what each represents.","No prior known state is provided in the prompt, so the \u201cwhat changed vs prior\u201d portion cannot be determined from the supplied text alone."],"key_facts":["SEC accession number: 0001856094-26-000003.","Form type: 4.","Issuer: RECURSION PHARMACEUTICALS, INC. (RXRX).","Reporting owner: Blake Borgeson.","Conformed period of report (transaction date): 2026-04-07.","Filed as of date: 2026-04-08.","The transaction is stated to be pursuant to a Rule 10b5-1 trading plan adopted on August 31, 2025.","The filing includes \u201cClass A Common Stock\u201d as the security referenced in the extracted text."],"numeric_claims":[{"label":"Filing date (as of)","value":"2026-04-08"},{"label":"Period of report (conformed)","value":"2026-04-07"},{"label":"Rule 10b5-1 plan adoption date","value":"2025-08-31"},{"label":"SEC accession number","value":"0001856094-26-000003"}],"primary_claim":"Form 4 for Recursion Pharmaceuticals, Inc. was filed on 2026-04-08 (covering period 2026-04-07) by reporting owner Blake Borgeson, and the transaction was pursuant to a Rule 10b5-1 trading plan adopted on August 31, 2025.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Recursion Pharmaceuticals, Inc. (RXRX) filed a Form 4 on 2026-04-08 covering a transaction dated 2026-04-07 by reporting owner Blake Borgeson. The filing states the trade was executed under a Rule 10b5-1 trading plan adopted on 2025-08-31.","topics":["SEC Form 4","insider trading","Rule 10b5-1","common stock transaction"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 RECURSION PHARMACEUTICALS, INC. \u00b7 Filed 20260408","ticker":"RXRX","tickers":["RXRX"],"title":"RXRX filed 4","url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt"}... |